CytRx Corp 60 pct own CytRx Biopool Ltd subsidiary acquire Biopool AB Umea Sweden undisclosed terms. It former shareholder Biopool AB remain 40 pct CytRx Biopool Ltd. Biopool AB develops cardiovascular fibrinolytic product diagnostic applications. The company CytRx Biopool study combination CytRx Corp's RheothRx drug reduce platelet aggregation viscosity blood Biopool AB's drug t-PA dissolve blood clots. Reuter 